PharmaCielo Ltd.
PCLOF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.34M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $10.34 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.01 |
| Beta | 1.06 |
| Outstanding Shares | 206,996,707 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -2.94 |
|---|---|
| PEG | -27.91 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
$5.17 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 26, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
$5.17 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About PharmaCielo Ltd.
268 employees
CEO: Marc Lustig
PharmaCielo Ltd., operating alongside its subsidiary, specializes in the cultivation, processing, production, and distribution of medical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated products. In addition...